Scott IU, Campochiaro PA, Newman NJ, Biousse V. Retinal vascular occlusions. Lancet. 2020;396:1927–40.

PubMed  PubMed Central  Google Scholar 

Campochiaro PA, Sophie R, Pearlman J, Brown DM, Boyer DS, Heier JS, et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study. Ophthalmology. 2014;121:209–19.

PubMed  Google Scholar 

Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology. 2012;119:802–9.

PubMed  Google Scholar 

Tadayoni R, Waldstein SM, Boscia F, Gerding H, Pearce I, Priglinger S, et al. Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of BRIGHTER. Ophthalmology. 2016;123:1332–44.

PubMed  Google Scholar 

Tadayoni R, Waldstein SM, Boscia F, Gerding H, Gekkieva M, Barnes E, et al. Sustained benefits of ranibizumab with or without laser in branch retinal vein occlusion: 24-month results of the BRIGHTER study. Ophthalmology. 2017;124:1778–87.

PubMed  Google Scholar 

Clark WL, Boyer DS, Heier JS, Haller JA, Vitti R, Kazmi H, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the VIBRANT study. Ophthalmology. 2016;123:330–6.

PubMed  Google Scholar 

Hoy SM. Aflibercept: a review in macular oedema secondary to branch retinal vein occlusion. Drugs Aging. 2017;34:393–400.

CAS  PubMed  Google Scholar 

Küçük B, Sirakaya E, Karaca C. Comparison of ranibizumab versus aflibercept in treating macular edema among patients with serous retinal detachment secondary to branch retinal vein occlusion. Ocul Immunol Inflamm. 2021;29:403–10.

PubMed  Google Scholar 

Hogg HDJ, Simplicio SD, Pearce MS. Ranibizumab and aflibercept intravitreal injection for treatment-naïve and refractory macular oedema in branch retinal vein occlusion. Eur J Ophthalmol. 2021;31:548–55.

PubMed  Google Scholar 

Sahni J, Patel SS, Dugel PU, et al. Simultaneous inhibition of angiopoietin-2 and vascular endothelial growth factor-A with faricimab in diabetic macular edema: BOULEVARD phase 2 randomized trial. Ophthalmology. 2021;126:1155–70.

Google Scholar 

Hattenbach LO, Abreu F, Arrisi P, Basu K, Danzig C, Guymer R, et al. BALATON and COMINO: phase III randomized clinical trials of faricimab for retinal vein occlusion study design and rationale. Opthalmol Sci. 2023;3: 100302.

Google Scholar 

Savant SV, Kwan JT, Barouch CJ, Ramsey DJ, Marx J, et al. Durability and efficacy of faricimab in treatment-resistant retinal edema utilizing “real-world” dosing regimens. J Ophthalmol. 2024;2024:8583348.

CAS  PubMed  PubMed Central  Google Scholar 

Wang R, McClard CK, Laswell S, Mamoudzadeh R, Salabati M, Ammar M, et al. Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALTII). BMJ Open Ophthalmol. 2022;7: e001188.

PubMed  PubMed Central  Google Scholar 

Daien V, Eldem BM, Talks JS, Korobelnik J-F, Mitchell P, Fnger RP, et al. Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy—systemic approach to identify and characterized data sources. BMC Ophthalmol. 2019;19:206.

PubMed  PubMed Central  Google Scholar 

Chugai Pharmaceutical Co., Ltd. Faricimab approval for retinal vein occlusion in Japan. Chugai News Release. Published 26 March 2024. https://www.chugai-pharm.co.jp/english/news/detail/20240326160000_1054.html Accessed 2 April 2025.

Zhang W, Liu Y, Sang A. Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis. BMC Ophthalmol. 2022;22:472.

CAS  PubMed  PubMed Central  Google Scholar 

Sasajima H, Zako M, Murotani K, Ueta Y, Tachi N, Ishida H, et al. Visual prognostic factors in eyes with subretinal fluid associated with branch retinal vein occlusion. J Clin Med. 2023;12:2909.

PubMed  PubMed Central  Google Scholar 

Hayreh SS, Zimmerman B, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol. 1994;117:429–41.

CAS  PubMed  Google Scholar 

Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ. 1995;310:170.

CAS  PubMed  PubMed Central  Google Scholar 

Hayreh SS, Zimmerman MB. Branch retinal vein occlusion. Natural history of visual outcome. JAMA Ophthalmol. 2014;132:13–22.

PubMed  Google Scholar 

McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, et al. Natural history of central retinal vein occlusion: an evidence-based systemic review. Ophthalmology. 2010;117:1113-23.e15.

PubMed  Google Scholar